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Objective: Thyroid hormones as modulators of adaptive thermogenesis can potentially contribute to
development of obesity. The purpose of our study is to observe a relationship between TSH and BMI,
blood lipids, BP and HbA1c in type 2 diabetic subjects with euthyroidism.
Methods: A total of 120 subjects with type 2 diabetes were recruited for this study from November 2012
to June 2014. Subjects were included in the study with TSH values between 0.4 and 4.5 mU/l, who did not
take any thyroid medication and had a similar iodine diet. Subjects were weighed and anthropometric
indices, lipid parameters, fasting plasma glucose, HbA1c, eGFR, blood pressure (BP) were documented.
TSH was measured by an electrochemiluminescence immunoassay. Statistical analysis was performed by
using SPSS 18(P value <0.05 was considered signiﬁcant).
Results: The mean age of the participants was 60.6 11.6 years with a BMI of 25.3 3.1 kg/m2. Serum TSH
levelswere signiﬁcantly and positively associatedwith BMI, systolic and diastolic BP, serum triglyceride and
HbA1c levels, whereas negatively with eGFR. Subjects with a TSH in a higher normal range (2.5e4.5 mU/I,
n ¼ 58) had a signiﬁcantly higher BMI (26.7  3 vs. 24.1  2.7) and this relation remained signiﬁcant
adjusted for age and sex (P < 0.001). When TSH was in low normal range, the number of patients with
glycemic goal (HbA1c > 7%) decreased from 27.5% to 12.5% (P ¼ 0.02, adjusted for age and sex).
Conclusion: In type 2 diabetic subjects with biochemical euthyroidism we found signiﬁcant association
between high normal TSH levels and components of metabolic syndrome. High normal TSH levels were
associated with more number of subjects with glycemic goal (HbA1c >7%).
 2015 The Author. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Sharply rising abdominal adiposity is probably themain cause of
MetS. In obese subjects, in the setting of insulin resistance, insulin is
unable to properly suppress accelerated free fatty acids (FFAs)
mobilization (lipolysis) from stored adipose tissue triglyceride [1,2].
Increased FFAs [3] also appear to cause insulin resistance. Both,
insulin resistance and increased fatty acids increase the sympa-
thetic nervous system activity and themselves contribute to vaso-
constriction [4,5] by triggering hypertension.ted hemoglobin; FPG, fasting
stolic blood pressure; HDL-c,
y lipoprotein cholesterol; TG,
lic syndrome.
ewer, statistic department of
nc. This is an open access article uIt is generally well accepted that hypothyroidism, with its
accompanying dyslipidemia and hypertension, similar to the com-
ponents of MetS is associated with CVD [6,7]. However, most car-
diovascular events occur in subjects with normal thyroid function,
and, little information is available about weight changes and insulin
resistance when thyroid functions are in the normal range. Some
investigators have suggested the existence of partially bio inactive
TSH in obese subjects [8]. Others display that there may be certain
thyroid hormone resistance. Ideally, early TH (thyroid hormone)
therapy and lowing high-normal TSH levels should increase fat loss
by stimulating thermogenesis and basal metabolic rate. Such ther-
apy is also justiﬁed in diabetic patients as FT3 has an anti-apoptotic
and protective effect on the pancreatic beta cells and higher
T3 levels induce kinase activity of the TR beta1-associated PI3
kinase and stimulates insulin secretion [9].
The aim of the study was to establish TSH levels associationwith
MetS components in insulin resistance subjects. It was further to
compare MetS components association with low normal and high
normal TSH levels in type 2 diabetic patients and to assess diabetes
control in patients with high-normal TSH levels.nder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Table 1
Clinical characteristics in subjects with low and higher normal TSH levels
Variables All subjects Subjects with T-test P value (2-tailed)
Low normal
TSH levels (0.4e2.49 mI/ml)
Higher normal*
TSH levels (2.5e4.5 mI/ml)
No (M/F) 120 (62/58) 62 (35/27) 58 (27/31) N/A N/S
Age 60.6  11.6 59.8  11.6 61.2  11.6 0.577 N/S (0.565)
BMI 25.3  3.1 24.1  2.7 26.7  3 4.957 <0.001
SBP 124.8  15.8 120.3  13.9 129.4  16.5 3.252 <0.01
DBP 75.7  11 73  10.2 78.6  11.3 2.797 <0.01
TG 137.8  84.4 n/p 117.6  75.4 159.4  88.5 2.788 <0.01
HDL-C 52.3  16.3 n/p 54  17.2 50.3  15.3 1.292 N/S (0.199)
LDL-C 97.6  31.8 95.3  32.1 99.4  31.5 0.600 N/S (0.550)
FPG 137.7  39.4 n/p 134.1  39.8 141.6  38.7 1.052 N/S (0.295)
HBA1C 7  1.3 n/p 6.6  1 7.5  1.3 3.827 <0.001
eGFR 77.7  20.8 82  19.8 73  21.2 2.424 N/S (>0.05)
*P value <0.05.
Fig. 1. Comparison of diabetes control in euthyroid MetS subjects with low normal and
high normal TSH levels.
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In our study, subjects, who met the inclusion criteria, were
120 Caucasian patients with type 2 diabetes mellitus. Patients who
met metabolic syndrome by WHO criteria [10], who were seeking
care to improve their diabetes control from November 2012 to June
2014 were evaluated for inclusion into this study. The exclusion
criteria were autoimmune conditions (Hashimoto thyroiditis,
Grave’s disease, type 1 diabetes or positive diabetes-related auto-
antibodies), medications for thyroid disease and medications, such
as steroids, dopamine, iodine, amiodarone. The inclusion criteria
were nonsmokers with euthyroidism (TSH values between 0.4 and
4.5 mU/l) and negative for thyroid autoantibodies (thyroid peroxi-
dase and thyroglobulin antibodies). Subjects recruited for this study
had a similar iodine diet. All the participants were given ques-
tionnaires to assess dietary habits. In addition, they were from the
same iodine deﬁciency zone. The study subjects were weighed and
their anthropometric indices were taken. Total cholesterol (TC), TG,
HDL-C, LDL-C, fasting plasma glucose (after 12 h fasting), HbA1c,
eGFR, SBP, DBP were documented, and TSH, FT4, FT3 were
measured by an electrochemiluminescence immunoassay. The
laboratory reference rangeswere 0.4e4.5mU/l for TSH. In our study
we used BMI (weight divided by the squared value of height) of
25.0 kg/m2 as cut-off for overweight and normal weight
individuals.
Statistical analysis
All correlation analyses were performed with partial correlation
analyses using TSH as a continuous variable. Adjustments were
made for age and gender. P < 0.05 was considered to indicate sta-
tistical signiﬁcance. Statistical analysis was performed on a per-
sonal computer using a statistical software package SPSS version
18.0 (SPSS Inc., Chicago, IL, USA).
Ethics
The study was approved by the regional ethics committee. All
subjects gave their written informed consent.
Results
Characteristics of study subjects
The mean age of the participants was 60.6  11.6 years with a
BMI of 25.3  3.1 kg/m2. TSH, FT4, and TT3 levels were not signif-
icantly different between male and female participants. Spearmanrank correlation coefﬁcient was used to determine associations
of variables with serum levels of TSH, FT4 and TT3. We found no
signiﬁcant association between FT4, TT3 and MetS components.
Thereby we focused on TSH for further analysis. Subjects with a TSH
in a higher normal range (2.5e4.5 mU/I, n ¼ 58) had a strong as-
sociationwith higher BMI (26.7 3 vs. 24.1 2.7) and HbA1c levels
(HbA1c > 7) (Table 1). This association remained signiﬁcant in
linear regression analysis after adjustment for sex and age
(P < 0.001). TSH was also associated with TG, SBP, DBP (P < 0.01),
but neither with eGFR and FPG (P > 0.05).
HbA1c
In the group with high-normal TSH levels, subjects with over-
weight or obesity (BMI e 25kg/m2 or higher) had about three times
higher prevalence of HbA1c > 7 levels (Fig. 1). The research shows,
that when TSH is in low normal range, the number of patients
with glycemic goal (HbA1c > 7%) decreases from 27.5% to 12.5%
(P ¼ 0.02, adjusted for age and sex).
MetS prevalence
The prevalence of MetS was 26% in this study population. Sub-
jects with high normal TSH levels (2.5e4.0 mIU/L) demonstrated a
signiﬁcantly higher prevalence of MetS than those with low normal
TSH levels (0.4e2.5 mIU/L) at a rate of 37.93% vs. 14.51% (P < 0.01).
Lipids
Among lipids only triglycerides were signiﬁcantly associated
with TSH levels (P< 0.05). Triglycerides were signiﬁcantly higher in
subjects in the upper normal TSH range comparedwith those in the
lownormal TSH range (159.4 88.5 vs.117.675.4, P¼ 0.006). Fig. 2
displays that mean of TG by categories of TSH is more obviously
increased in subjects with normal weight than in overweight/obese
subjects (adjusted for age, sex and time since last meal).
Fig. 2. Mean TG by categories of TSH.
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There were no associations between TSH levels and medications
used for the treatment of diabetes, dyslipidemia and hypertension
(Table 2).Discussion
Insulin sensitivity and TSH
There are many reports about the association between thyroid
hormones and MetS in non-diabetic subjects. But reports about the
relationship between thyroid hormones and MetS components in
type 2 diabetic patients are very rare. In our study, we found not
only a positive association between TSH levels and MetS compo-
nents in diabetic subjects, but we also could show that diabetes
control was somehow complicated when subjects had a high-
normal range of TSH. Some studies described decreased insulin
sensitivity in hypothyroidism [11,12], while others did not [13,14].
The study of Jackson et al. even reported increased insulin sensi-
tivity [15]. Recently, an experimental study in an animal model has
demonstrated that the mutation in the a-isoform of the thyroid
hormone receptor caused insulin resistance and thyroid hormone
resistance [16]. In addition, studies investigating thyroid hormone
receptors in MetS subjects (mostly in obese individuals) demon-
strated a decrease of thyroid hormone receptor density [17,18].
In our study we found no signiﬁcant association between
FT4 and total T3 levels with Mets components in diabetic subjects.
This may be explained that T3 levels in the normal range do not
have very strong physiological activity and do not reﬂect in pe-
ripheral tissue, which are known to actually exert the metabolic
effects. There are also differences in expression of thyroid hormone
receptors on central and peripheral tissues and can, therefore, alsoTable 2
Regression analyses
Medications Number of subjects P value
Diet only 23 N/S (0.074)
OHAs 76 N/S (0.188)
Insulin 11 N/S (0.084)
Insulin þ OHAs 10 N/S (0.192)
Anti-hypertensive drugs () 94
(þ) 26
N/S (0.241)
Lipid-lowering drugs () 80
(þ) 40
N/S (0.969)play a role in inducing a discrepancy of thyroid hormones effects in
central and peripheral tissues [19].
BMI and TSH
Our data revealed positive association between TSH and BMI.
This association could be affected by a third factor. To control for the
effect of age, age was included as an independent variable in the
multiple regression analysis. Furthermore, the positive association
between TSH and BMI was also signiﬁcant in those above the age of
50. Age was therefore an unlikely explanation for the association
between elevated TSH and BMI. Moreover, this association could be
causal. Many reports have shown that after reducing body weight
or after bariatric surgery [20,21], there was a signiﬁcant decrease in
TSH levels. The mechanism could be explained by the leptin levels
secreted by adipose tissue, which is directly correlated to the
amount of adipose tissue. In experimental stage, leptin has been
reported to stimulate the biosynthesis of TSH [22]. On the other
hand, we could not ignore the possible role of hyperglycemia on
TSH-depend BMI levels.
Lipids and TSH
Among MetS components TSH was correlated with triglyceride
levels. In 1980s: it was demonstrated that LDL receptor activity was
regulated by thyroid hormone [23]. Increased level of triglycerides
in high-normal TSH subjects could be caused by a reduced activity
of lipoprotein lipase, or impaired clearance of lipoproteins depen-
dent on LDL receptor function. LDL-C clearance is different between
subjects with high normal and subjects with low normal TSH levels
[24]. In our study this difference remained unnoticed, probably,
because of insulin resistance. In the liver of insulin-resistant
patients, triglyceride synthesis and storage are increased, and
excess triglyceride is secreted as VLDL [25]. However, LDL-C con-
centrations remain essentially unchanged in insulin-resistant states
because of a decrease in cholesterol content per LDL particle,
resulting in higher concentrations of small dense LDL particles
[10,26,27]. This positive association between TSH levels and TG
could have long-term harmful effects on cardiovascular disease.
Study limitation
The main limitation of our study is the relatively small size and
regional homogeneity of the population visiting the aforemen-
tioned Hospital. This data does not reﬂect that of the general pop-
ulation. Further larger randomized trials are necessary to evaluate
increased risk of early stage of thyroid dysfunction and to display
the potential beneﬁt for the earlier stage management of thyroid
dysfunction.
Conclusion
In summary, we found a signiﬁcant association between high
normal TSH levels and components of metabolic syndrome in type
2 diabetic subjects with biochemical euthyroidism. High normal
TSH levels were associated with more diabetic subjects with
glycemic goal (HbA1c > 7%).
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